ResMed (RMD) Debt/EBITDA US GAAP (year values) |
|||||||||
2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 0.55 | 1.01 | 1.00 | 0.38 | 0.40 | 0.24 | |||
Changes by years, y/y, % | +84% | -1% | -62% | +6% | -21.5% |
ResMed. Debt/EBITDA
ResMed. Debt/EBITDA, changes, %
ResMed (RMD) Debt/EBITDA US GAAP (quarter values) |
||||||||
2024Q3 | 2024Q3 | 2024Q4 | 2024Q4 | 2025Q1 | LTM ? | |||
Debt/EBITDA | 0.64 | 0.62 | 0.39 | 0.40 | 0.25 | 0.24 | ||
Changes by years, y/y, % | -44% | -46% | -61% | -60% | -73% | |||
Changes by quarters, q/q, % | -23% | -3% | -37% | +3% | -37% |